Dry Powder Inhalers (dpis) - Neonatal Disorders

Relevant Publications

Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.

Issue Release: 2024

Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for improved targeted pulmonary delivery.

Issue Release: 2024

Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.

Issue Release: 2024

Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea.

Issue Release: 2024

Quality by Design in Pulmonary Drug Delivery: A Review on Dry Powder Inhaler Development, Nanotherapy Approaches, and Regulatory Considerations.

Issue Release: 2024

Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosis.

Issue Release: 2024

The environmental burden of inhalation.

Issue Release: 2024

Maintenance Inhalers for Asthma and COPD in Spain.

Issue Release: 2024

Evaluation of a Novel Pediatric Asthma Inhalation Drug Delivery Device: A Focus on Patient Accessibility, Ease of Use, Dosage Feedback, and Future Directions.

Issue Release: 2024

Effect on Physical Position of Peak Inspiratory Flow in Stable COPD: An Observational Study.

Issue Release: 2024

Aerosol Plumes of Inhalers Used in COPD.

Issue Release: 2024

Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.

Issue Release: 2024

Preparation and Evaluation of Inhalable Microparticles with Improved Aerodynamic Performance and Dispersibility Using L-Leucine and Hot-Melt Extrusion.

Issue Release: 2024

Understanding the role of swirling flow in dry powder inhalers implications for design considerations and pulmonary delivery.

Issue Release: 2024

Spray-Dried Nanolipid Powders for Pulmonary Drug Delivery: A Comprehensive Mini Review.

Issue Release: 2024

Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation.

Issue Release: 2024

Design and comprehensive characterization of dry powder inhalation aerosols of simvastatin DPPC/DPPG lung surfactant-mimic nanoparticles/microparticles for pulmonary nanomedicine.

Issue Release: 2024

Successful Use of Easyhaler Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials.

Issue Release: 2024

Comparative study of the inhalation parameters of COPD patients through NEXThaler® and Ellipta® dry powder inhalers.

Issue Release: 2024

Cryomilled electrospun nanofiber mats containing d-mannitol exhibit suitable for aerosol delivery of proteins.

Issue Release: 2024

What Causes Pediatric Nephropathy?

What are Some Examples of Tailored Treatment in Pediatrics?

Why are Developmental Therapies Important?

How Can Pediatricians Help Underprivileged Children?

How Can Lung Immaturity Be Prevented?

What is the Neonatal Infant Pain Scale (NIPS)?

How Often Should Blood Glucose be Monitored?

What is Rhinovirus?

What are the benefits of using APIs in Pediatric Healthcare?

What Are Environmental Factors?

Partnered Content Networks

Relevant Topics